First Trust Advisors
AMAG

First Trust Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

First Trust Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-70,869
Closed -$1.38M – 2571
2018
Q2 		$1.38M Buy
70,869
+36,607
+107% +$810K ﹤0.01% 1801
2018
Q1 		$690K Buy
34,262
+5
+0% +$85 ﹤0.01% 1928
2017
Q4 		$454K Sell
34,257
-5,586
-14% -$84.2K ﹤0.01% 2122
2017
Q3 		$735K Buy
+39,843
New +$743K ﹤0.01% 1959
2017
Q2 		– Sell
-55,055
Closed -$1.24M – 2487
2017
Q1 		$1.24M Buy
55,055
+18,227
+49% +$436K ﹤0.01% 1770
2016
Q4 		$1.28M Buy
36,828
+15,996
+77% +$478K ﹤0.01% 1713
2016
Q3 		$511K Buy
+20,832
New +$521K ﹤0.01% 1991

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Trust Advisors's AMAG Position: Q3 2018 in Review

First Trust Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q3 2018, closing a stake of 70,869 shares — an estimated $1.38M sold.

First Trust Advisors first reported a position in AMAG in Q3 2016 and held it in 7 quarters. The position peaked at $1.38M in Q2 2018. 182 funds tracked by Wall St. Rank hold AMAG as of Q3 2018.

  • First Trust Advisors reported no remaining AMAG Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • First Trust Advisors sold 70,869 AMAG Pharmaceuticals shares in Q3 2018, an estimated $1.38M.
  • First Trust Advisors first reported a position in AMAG Pharmaceuticals in Q3 2016 and held it in 7 quarters.
  • First Trust Advisors's AMAG Pharmaceuticals position peaked at $1.38M in Q2 2018.
  • 182 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2018.

Based on First Trust Advisors's 13F filing for Q3 2018, filed 25 Oct 2018.